Likewise, while administration of AAV-YAPdeltaC protects against cognitive decline and pathological changes, including increased extracellular Aβ and ER instability, in 5xFAD and APP-KI mice, intracellular Aβ levels remain unchanged [17]. The gene discussed is APP; the disease is Mental deterioration.